• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.

作者信息

Thananopavarn C, Golub M S, Eggena P, Barrett J D, Sambhi M P

出版信息

Circulation. 1980 May;61(5):920-4. doi: 10.1161/01.cir.61.5.920.

DOI:10.1161/01.cir.61.5.920
PMID:6988103
Abstract

To evaluate the role of the renin-angiotensin system and sodium depletion in the hypotensive response to 1-sarcosine-8-alanine-angiotensin II (saralasin), 15 male patients with essential hypertension were studied on a diet containing 120 mEq of sodium and 100 mEq of potassium per day. After a 5-day control period, all subjects had a mild pressor response to the saralasin infusion (p less than 0.01). After 5 days of the diuretic metolazone (5 mg/day), eight of the 15 patients had a vasodepressor response; these responders had a significantly greater increase in plasma renin activity and angiotensin II concentrations than did the non-responders. Sodium deficit differed markedly (p less than 0.001) between the two groups (361 +/- 121 mEq (SD) vs 52 +/- 26 mEq sodium, respectively). The addition of spironolactone (400 mg/day) for 5 days resulted in saralasin responsiveness in all but two patients, both of whom had small sodium deficits. Thus, variability in the natriuretic response to diuretics may affect saralasin testing and limit its clinical utility.

摘要

相似文献

1
Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
Circulation. 1980 May;61(5):920-4. doi: 10.1161/01.cir.61.5.920.
2
Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
Ann Intern Med. 1977 Aug;87(2):176-82. doi: 10.7326/0003-4819-87-2-176.
3
Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
Clin Sci Mol Med. 1978 Jan;54(1):75-83. doi: 10.1042/cs0540075.
4
[Saralasin in subjects with low renin arterial hypertension].[低肾素性动脉高血压患者使用沙拉新的研究]
Boll Soc Ital Biol Sper. 1980 Jul 15;56(13):1367-73.
5
Diuretic therapy and response of essential hypertension to saralasin.
Ann Intern Med. 1977 Aug;87(2):183-7. doi: 10.7326/0003-4819-87-2-183.
6
The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.血管紧张素II拮抗剂沙拉新对正常人和高血压患者血压及肾素-血管紧张素-醛固酮系统的影响。
Aust N Z J Med. 1976 Aug;6(3 Suppl):48-52. doi: 10.1111/j.1445-5994.1976.tb03335.x.
7
Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.高血压患者对1-肌氨酸-8-丙氨酸-血管紧张素II(沙拉新)的升压反应。
Circ Res. 1977 Mar;40(3):243-50. doi: 10.1161/01.res.40.3.243.
8
Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
Klin Wochenschr. 1978;56 Suppl 1:97-105. doi: 10.1007/BF01477460.
9
Pressor response to saralasin (1-sar-8-ala-angiotensin II) bolus injection in hypertensive patients.
Circulation. 1978 Jun;57(6):1165-70. doi: 10.1161/01.cir.57.6.1165.
10
Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
Eur J Clin Pharmacol. 1977 Aug 17;12(1):1-5. doi: 10.1007/BF00561398.

引用本文的文献

1
Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms.高血压研讨会:正常与异常血压调节机制的新话题
West J Med. 1983 Aug;139(2):190-203.